[A novel high quality specific antithrombotic drug--hirudin].
Tao Li, C Wan, Li Y, Huijun Chen
Abstract
Tao Li, C Wan, Li Y, Huijun Chen
Abstract
Hirudin is the most potent specific inhibitor of thrombin, which is currently undergoing clinical trials as a novel antithrombotic drug. In this paper, the composition and structure, the pharmacological and pharmacokinetic characteristics, the anticoagulant and antithrombotic activity and function, the methods of isolation, recombination and syntheses were reviewed.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Hirudin is the most potent specific inhibitor of thrombin, which is currently undergoing clinical trials as a novel antithrombotic drug. In this paper, the composition and structure, the pharmacological and pharmacokinetic characteristics, the anticoagulant and antithrombotic activity and function, the methods of isolation, recombination and syntheses were reviewed.
Key concepts: Antithrombotic, Hirudin, Discovery and development of direct thrombin inhibitors, Drug, Anticoagulant, Pharmacology, Thrombin, Medicine